# Clinical Studies of Gemcitabine-Oxaliplatin

> **NCT00407433** · PHASE2 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 156 (estimated)

## Conditions studied

- Medulloblastoma
- Central Nervous System Tumors
- Neuroblastoma
- Osteosarcoma

## Interventions

- **DRUG:** Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)

## Key facts

- **NCT ID:** NCT00407433
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2009-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407433, "Clinical Studies of Gemcitabine-Oxaliplatin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00407433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*